Welcome to LookChem.com Sign In | Join Free Post buying lead Chemical Tools
Home > Hot Product_List > Thiamine hydrochloride

Basic information

  • Name:
  • Thiazolium,3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl-chloride (1:1), hydrochloride (1:1)

  • Superlist Name:
  • Thiamine hydrochloride
  • CAS No.:
  • 67-03-8

  • Molecular Structure:
  • Formula:
  • C12H17ClN4OS.HCl
  • Molecular Weight:
  • 337.27
  • Synonyms:
  • Thiamine,monohydrochloride (8CI);Thiazolium,3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl-chloride, monohydrochloride (9CI);Thiamol;Thiavit;Tiamidon;Vetalin S;Vitaneuron;3-(4-Amino-2-methylpyrimidyl-5-methyl)-4-methyl-5,b-hydroxyethylthiazolium chloride hydrochloride;Aneurine hydrochloride;Apate drops;Beatine;Bedome;Benerva;Bequin;Berin;Bethiazine;Beuion;Bewon;Biuno;Bivita;Clotiamina;Eskaphen;Lixa-Beta;Slowten;Thiamindichloride;Thiaminal;Thiamine chloride;Thiaminechloride hydrochloride;Thiamine dichloride;Thiaminiumchloride;Thiaminium chloride hydrochloride;Vitamin B1 Hcl;
  • EINECS:
  • 200-641-8
  • Melting Point:
  • 250 °C (dec.)(lit.)
  • Solubility:
  • 1 g/mL in water
  • Appearance:
  • White crystalline powder
  • Hazard Symbols:
  • IrritantXi
  • Risk Codes:
  • 36/37/38
  • Safety Description:
  • 22-24/25-37/39-26-36 Details
  • particular:
  • particular

Famous Chemical Enterprises

  • Livzon
  • Total
  • Shell
  • Dupont
  • Exxonmobil
  • Akzonobel
  • Basf
  • Bayer
  • BP

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Specification

The Thiamine hydrochloride is an organic compound with the formula C12H17ClN4OS.HCl. The IUPAC name of this chemical is 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol chloride hydrochloride. With the CAS registry number 67-03-8, it is also named as 3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride hydrochloride. The product's categories are Biochemistry; Vitamins; Vitamins and Derivatives; Vitamin Ingredients; Miscellaneous Compounds. Besides, it is a white crystalline powder, which should be stored in a closed dark and cool place.

All living organisms use thiamine in their biochemistry, but it is synthesized in bacteria, fungi, and plants. Animals must obtain it from their diet, and, thus, for them it is a vitamin. Insufficient intake in birds produces a characteristic polyneuritis, and in mammals results in a disease called beriberi affecting the peripheral nervous system (polyneuritis) and/or the cardiovascular system, with fatal outcome if not cured by thiamine administration. In less severe deficiency, nonspecific signs include malaise, weight loss, irritability and confusion. Thiamine derivatives with improved pharmacokinetics have been discovered and are to be considered more effective in alleviating the symptoms of thiamine deficiency and other thiamine-related conditions such as impaired glucose metabolism in diabetes.

Physical properties about Thiamine hydrochloride are: (1)#H bond acceptors: 5; (2)#H bond donors: 3; (3)#Freely Rotating Bonds: 5; (4)Polar Surface Area: 70.37 Å2.

Uses of Thiamine hydrochloride: it can be used to produce 3-(4-amino-2-methyl-pyrimidin-5-ylmethyl)-5-(2-hydroxy-ethyl)-4-methyl-thiazolium; chloride. It will need reagent aq. NaOH and solvent ethanol. The yield is about 100%.

When you are using this chemical, please be cautious about it as the following:
This chemical is irritating to eyes, respiratory system and skin. When you are using it, wear suitable gloves and eye/face protection, do not breathe dust and avoid contact with skin and eyes. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
(1)SMILES: [Cl-].Cl.n1c(c(cnc1C)C[n+]2c(c(sc2)CCO)C)N
(2)InChI: InChI=1/C12H17N4OS.2ClH/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13;;/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15);2*1H/q+1;;/p-1
(3)InChIKey: DPJRMOMPQZCRJU-REWHXWOFAZ
(4)Std. InChI: InChI=1S/C12H17N4OS.2ClH/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13;;/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15);2*1H/q+1;;/p-1
(5)Std. InChIKey: DPJRMOMPQZCRJU-UHFFFAOYSA-M

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LD50 intravenous 75mg/kg (75mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 6, Pg. 623, 1956.
frog LD50 subcutaneous 2600mg/kg (2600mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 9, Pg. 1, 1959.
guinea pig LD50 intravenous 140mg/kg (140mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 6, Pg. 623, 1956.
guinea pig LD50 subcutaneous 872mg/kg (872mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 6, Pg. 623, 1956.
mouse LD50 intraperitoneal 200mg/kg (200mg/kg)   National Technical Information Service. Vol. AD277-689,
mouse LD50 intravenous 74mg/kg (74mg/kg)   Farmaco, Edizione Pratica. Vol. 24, Pg. 712, 1969.
mouse LD50 oral 8224mg/kg (8224mg/kg)   Internationale Zeitschrift fuer Vitaminforschung. International Review of Vitamin Research. Vol. 37, Pg. 82, 1967.
mouse LD50 subcutaneous 266mg/kg (266mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967.
pigeon LD50 intravenous 180mg/kg (180mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 6, Pg. 623, 1956.
rabbit LD50 intravenous 117mg/kg (117mg/kg) BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)

LUNGS, THORAX, OR RESPIRATION: CYANOSIS

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Proceedings of the Society for Experimental Biology and Medicine. Vol. 68, Pg. 153, 1948.
rat LD50 intraperitoneal 481mg/kg (481mg/kg)   Farmaco, Edizione Pratica. Vol. 24, Pg. 712, 1969.
rat LD50 intravenous 118mg/kg (118mg/kg)   Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 236, Pg. 149, 1959.
rat LD50 oral 3710mg/kg (3710mg/kg) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE

BEHAVIORAL: TREMOR

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Agents and Actions, A Swiss Journal of Pharmacology. Vol. 4, Pg. 125, 1974.
rat LD50 subcutaneous 560mg/kg (560mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 6, Pg. 623, 1956.
women LDLo intramuscular 5mg/kg (5mg/kg) BEHAVIORAL: COMA

VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION
American Journal of Emergency Medicine. Vol. 13, Pg. 371, 1995.

Please post your buying leads
so that our qualified suppliers will soon contact you!

©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

[Hangzhou]86-571-85317600,85317603,85317620